抗体介导的免疫反应与非酒精性脂肪性肝病:一项双向孟德尔随机化研究
Antibody-Mediated Immune Response and Non-Alcoholic Fatty Liver Disease: A Bidirectional Mendelian Randomization Study
DOI: 10.12677/acm.2024.14112910, PDF,   
作者: 陈阮昶, 周方正:绍兴文理学院医学院,浙江 绍兴;绍兴市人民医院肝胆胰外科,浙江 绍兴;章佳瑶:绍兴市人民医院肝胆胰外科,浙江 绍兴;浙江大学医学院,浙江 杭州;鲁葆春*:绍兴市人民医院肝胆胰外科,浙江 绍兴
关键词: 孟德尔随机化抗体介导的免疫反应非酒精性脂肪性肝病因果关系Mendelian Randomization Antibody-Mediated Immune Response Non-Alcoholic Fatty Liver Disease Causality
摘要: 背景:先前的研究已将抗体介导的免疫反应与非酒精性脂肪性肝病(NAFLD)联系起来,但其因果关系仍不明确。目的:进一步明确抗体免疫反应与NAFLD之间的因果关系。方法:抗体介导的免疫反应和NAFLD的汇总统计数据来自欧洲人群的全基因组关联研究(GWAS)。研究采用双向孟德尔随机化分析,主要通过逆方差加权法(IVW)评估46种抗体介导的免疫反应与NAFLD之间的因果关系。潜在的多效性使用MR-Egger和MR-PRESSO法进行评估,异质性通过Cochran’s Q检验进行检测,敏感性分析则采用leave-one-out法进行评估。结果:基于IVW的孟德尔随机化分析结果表明,两种抗体介导的免疫反应可能会增加NAFLD的风险:(沙眼衣原体tarp-D F1抗体水平:OR 1.068, 95% CI: 1.006~1.133, P-value = 0.032和幽门螺杆菌UREA抗体水平:OR 1.084, 95% CI: 1.001~1.174, P-value = 0.047)。反向孟德尔随机化显示,随着NAFLD风险的增加,幽门螺杆菌UREA抗体水平和抗单纯疱疹病毒1型IgG血清阳性也增加。相反,抗沙眼衣原体IgG血清阳性和抗多瘤病毒2 IgG血清阳性则呈下降趋势。结论:这项研究证实了抗体介导的免疫反应与NAFLD之间的因果关系,为免疫反应在NAFLD发展中的作用提供了新的证据,对NAFLD的预防和治疗具有重要意义。
Abstract: Background: Previous studies have linked antibody-mediated immune responses to non-alcoholic fatty liver disease (NAFLD), but the causal relationship remains unclear. Aims: To further understand the causal relationship between immune responses and NAFLD. Methods: Summary statistics for antibody-mediated immune response and NAFLD were derived from GWAS data based on European participants. Bidirectional Mendelian randomization mainly applying Inverse variance weighted (IVW) method was employed to assess the causal relationships between 46 antibody-mediated immune responses and NAFLD. Potential pleiotropy was evaluated using MR-Egger and MR-PRESSO methods, heterogeneity was examined with Cochran’s Q test, and sensitivity was assessed through leave-one-out analysis. Results: Based on IVW method, our Mendelian randomization showed that two antibody-mediated immune responses potentially causally increase NAFLD risk (Chlamydia trachomatis tarp-D F1 antibody levels: OR 1.068, 95% CI: 1.006~1.133, P-value = 0.032 and Helicobacter pylori UREA antibody levels: OR 1.084, 95% CI: 1.001~1.174, P-value = 0.047). Reverse Mendelian randomization revealed increased NAFLD risk causally associated with higher Helicobacter pylori UREA antibody levels and Anti-herpes simplex virus 1 IgG seropositivity. Conversely, Anti-Chlamydia trachomatis IgG and Anti-polyomavirus 2 IgG seropositivity showed a decreasing trend. There was no evidence of heterogeneity or horizontal pleiotropy detected. Conclusions: This study confirms causal relationships between antibody-mediated immune response and NAFLD, offering new evidence for the role of immune responses in NAFLD development and presenting significant implications for its prevention and treatment.
文章引用:陈阮昶, 周方正, 章佳瑶, 鲁葆春. 抗体介导的免疫反应与非酒精性脂肪性肝病:一项双向孟德尔随机化研究[J]. 临床医学进展, 2024, 14(11): 522-530. https://doi.org/10.12677/acm.2024.14112910

参考文献

[1] Younossi, Z., Anstee, Q.M., Marietti, M., Hardy, T., Henry, L., Eslam, M., et al. (2017) Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention. Nature Reviews Gastroenterology & Hepatology, 15, 11-20. [Google Scholar] [CrossRef] [PubMed]
[2] Golabi, P., Owrangi, S. and Younossi, Z.M. (2024) Global Perspective on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis—Prevalence, Clinical Impact, Economic Implications and Management Strategies. Alimentary Pharmacology & Therapeutics, 59, S1-S9. [Google Scholar] [CrossRef] [PubMed]
[3] Fan, J., Kim, S. and Wong, V.W. (2017) New Trends on Obesity and NAFLD in Asia. Journal of Hepatology, 67, 862-873. [Google Scholar] [CrossRef] [PubMed]
[4] Tilg, H., Moschen, A.R. and Roden, M. (2016) NAFLD and Diabetes Mellitus. Nature Reviews Gastroenterology & Hepatology, 14, 32-42. [Google Scholar] [CrossRef] [PubMed]
[5] Deprince, A., Haas, J.T. and Staels, B. (2020) Dysregulated Lipid Metabolism Links NAFLD to Cardiovascular Disease. Molecular Metabolism, 42, Article 101092. [Google Scholar] [CrossRef] [PubMed]
[6] Seifert, M. and Küppers, R. (2016) Human Memory B Cells. Leukemia, 30, 2283-2292. [Google Scholar] [CrossRef] [PubMed]
[7] Luo, W., Gan, J., Luo, Z., Li, S., Wang, Z., Wu, J., et al. (2024) Safety, Immunogenicity and Protective Effectiveness of Heterologous Boost with a Recombinant COVID-19 Vaccine (Sf9 Cells) in Adult Recipients of Inactivated Vaccines. Signal Transduction and Targeted Therapy, 9, Article No. 41. [Google Scholar] [CrossRef] [PubMed]
[8] Dyda, A., Broome, A., Rawlinson, W., Mahimbo, A., Saha, A., Kefalas, B., et al. (2024) Measles, Mumps, Rubella and Varicella Antibodies among International and Domestic University Students. Journal of Travel Medicine, 31, taae004. [Google Scholar] [CrossRef] [PubMed]
[9] Katzelnick, L.C., Gresh, L., Halloran, M.E., Mercado, J.C., Kuan, G., Gordon, A., et al. (2017) Antibody-Dependent Enhancement of Severe Dengue Disease in Humans. Science, 358, 929-932. [Google Scholar] [CrossRef] [PubMed]
[10] O’Connor, S.M., Taylor, C.E. and Hughes, J.M. (2006) Emerging Infectious Determinants of Chronic Diseases. Emerging Infectious Diseases, 12, 1051-1057. [Google Scholar] [CrossRef] [PubMed]
[11] Huby, T. and Gautier, E.L. (2021) Immune Cell-Mediated Features of Non-Alcoholic Steatohepatitis. Nature Reviews Immunology, 22, 429-443. [Google Scholar] [CrossRef] [PubMed]
[12] Chumak, A.A., Nosach, O.V., Ovsyannikova, L.M., Alekhina, S.M., Pleskach, O.Y., Sarkisova, E.O., et al. (2014) Peculiarities of Viruses Herpesviridae Family Persistence in Patients with Non-Alcoholic Fatty Liver Disease Who Had Been Exposed to the Factors of Chornobyl NPP Accident. Problemy Radiatsiinoi Medytsyny ta Radiobiolohii, 19, 361-370.
[13] Abo-Amer, Y.E., Sabal, A., Ahmed, R., Hasan, N.F.E., Refaie, R., Mostafa, S.M., et al. (2020) Relationship between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 619-625. [Google Scholar] [CrossRef] [PubMed]
[14] Baeg, M.K., Yoon, S.K., Ko, S.H., Noh, Y.S., Lee, I.S. and Choi, M.G. (2016) Helicobacter pylori Infection Is Not Associated with Nonalcoholic Fatty Liver Disease. World Journal of Gastroenterology, 22, 2592-2600. [Google Scholar] [CrossRef] [PubMed]
[15] Han, Y.M., Lee, J., Choi, J.M., Kwak, M., Yang, J.I., Chung, S.J., et al. (2021) The Association between Helicobacter pylori with Nonalcoholic Fatty Liver Disease Assessed by Controlled Attenuation Parameter and Other Metabolic Factors. PLOS ONE, 16, e0260994. [Google Scholar] [CrossRef] [PubMed]
[16] Larsson, S.C., Butterworth, A.S. and Burgess, S. (2023) Mendelian Randomization for Cardiovascular Diseases: Principles and Applications. European Heart Journal, 44, 4913-4924. [Google Scholar] [CrossRef] [PubMed]
[17] Butler-Laporte, G., Kreuzer, D., Nakanishi, T., Harroud, A., Forgetta, V. and Richards, J.B. (2020) Genetic Determinants of Antibody-Mediated Immune Responses to Infectious Diseases Agents: A Genome-Wide and HLA Association Study. Open Forum Infectious Diseases, 7, ofaa450. [Google Scholar] [CrossRef] [PubMed]
[18] Kurki, M.I., Karjalainen, J., Palta, P., Sipilä, T.P., Kristiansson, K., Donner, K.M., et al. (2023) FinnGen Provides Genetic Insights from a Well-Phenotyped Isolated Population. Nature, 613, 508-518. [Google Scholar] [CrossRef] [PubMed]
[19] Evans, D.M. and Davey Smith, G. (2015) Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. Annual Review of Genomics and Human Genetics, 16, 327-350. [Google Scholar] [CrossRef] [PubMed]
[20] Li, P., Wang, H., Guo, L., Gou, X., Chen, G., Lin, D., et al. (2022) Association between Gut Microbiota and Preeclampsia-Eclampsia: A Two-Sample Mendelian Randomization Study. BMC Medicine, 20, Article No. 443. [Google Scholar] [CrossRef] [PubMed]
[21] Burgess, S. and Thompson, S.G. (2017) Interpreting Findings from Mendelian Randomization Using the MR-Egger Method. European Journal of Epidemiology, 32, 377-389. [Google Scholar] [CrossRef] [PubMed]
[22] A, G., Sun, C., Shan, Y., Husile, H. and Bai, H. (2022) Bidirectional Causal Link between Inflammatory Bowel Disease and Celiac Disease: A Two-Sample Mendelian Randomization Analysis. Frontiers in Genetics, 13, Article 993492. [Google Scholar] [CrossRef] [PubMed]
[23] Jury, B., Fleming, C., Huston, W.M. and Luu, L.D.W. (2023) Molecular Pathogenesis of Chlamydia trachomatis. Frontiers in Cellular and Infection Microbiology, 13, Article 1281823. [Google Scholar] [CrossRef] [PubMed]
[24] Caven, L. and Carabeo, R.A. (2019) Pathogenic Puppetry: Manipulation of the Host Actin Cytoskeleton by Chlamydia trachomatis. International Journal of Molecular Sciences, 21, Article 90. [Google Scholar] [CrossRef] [PubMed]
[25] Pierantonelli, I. and Svegliati-Baroni, G. (2019) Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression from NAFLD to Nash. Transplantation, 103, e1-e13. [Google Scholar] [CrossRef] [PubMed]
[26] Fischbach, W. and Malfertheiner, P. (2018) Helicobacter pylori Infection: When to Eradicate, How to Diagnose and Treat. Deutsches Ärzteblatt international, 115, 429-436. [Google Scholar] [CrossRef] [PubMed]
[27] Xu, X., Li, W., Qin, L., Yang, W., Yu, G. and Wei, Q. (2019) Relationship between Helicobacter pylori Infection and Obesity in Chinese Adults: A Systematic Review with Meta-Analysis. PLOS ONE, 14, e0221076. [Google Scholar] [CrossRef] [PubMed]
[28] Kato, M., Toda, A., Yamamoto‐Honda, R., Arase, Y. and Sone, H. (2019) Association between Helicobacter pylori Infection, Eradication and Diabetes Mellitus. Journal of Diabetes Investigation, 10, 1341-1346. [Google Scholar] [CrossRef] [PubMed]
[29] Sun, Y., Fu, D., Wang, Y.K., Liu, M. and Liu, X.D. (2016) Prevalence of Helicobacter pylori Infection and Its Association with Lipid Profiles. Bratislava Medical Journal, 117, 521-524. [Google Scholar] [CrossRef] [PubMed]
[30] Polyzos, S.A., Kountouras, J., Papatheodorou, A., Patsiaoura, K., Katsiki, E., Zafeiriadou, E., et al. (2013) Helicobacter pylori Infection in Patients with Nonalcoholic Fatty Liver Disease. Metabolism, 62, 121-126. [Google Scholar] [CrossRef] [PubMed]
[31] Liu, Y., Xu, H., Zhao, Z., Dong, Y., Wang, X. and Niu, J. (2022) No Evidence for a Causal Link between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease: A Bidirectional Mendelian Randomization Study. Frontiers in Microbiology, 13, Article 1018322. [Google Scholar] [CrossRef] [PubMed]
[32] Cole, S. (2020) Herpes Simplex Virus: Epidemiology, Diagnosis, and Treatment. Nursing Clinics of North America, 55, 337-345. [Google Scholar] [CrossRef] [PubMed]
[33] James, C., Harfouche, M., Welton, N.J., Turner, K.M., Abu-Raddad, L.J., Gottlieb, S.L., et al. (2020) Herpes Simplex Virus: Global Infection Prevalence and Incidence Estimates, 2016. Bulletin of the World Health Organization, 98, 315-329. [Google Scholar] [CrossRef] [PubMed]
[34] Mayberry, C.L., Bond, A.C., Wilczek, M.P., Mehmood, K. and Maginnis, M.S. (2021) Sending Mixed Signals: Polyomavirus Entry and Trafficking. Current Opinion in Virology, 47, 95-105. [Google Scholar] [CrossRef] [PubMed]
[35] Shackelton, L.A., Rambaut, A., Pybus, O.G. and Holmes, E.C. (2006) JC Virus Evolution and Its Association with Human Populations. Journal of Virology, 80, 9928-9933. [Google Scholar] [CrossRef] [PubMed]
[36] Bofill-Mas, S., Formiga-Cruz, M., Clemente-Casares, P., Calafell, F. and Girones, R. (2001) Potential Transmission of Human Polyomaviruses through the Gastrointestinal Tract after Exposure to Virions or Viral DNA. Journal of Virology, 75, 10290-10299. [Google Scholar] [CrossRef] [PubMed]